Ikris Pharma Network and the Evolving Landscape of Pharmaceutical Distribution in India


The pharmaceutical industry is changing rapidly. Due to increasing chronic diseases and after the Covid-19 outbreak, there came a massive boom in the pharma industry. Thus the pharmaceutical organizations and manufacturers began to manufacture and supply medicines and medical equipment faster to meet the requirements of the patients. Pharmaceutical distributors work more than an intermediary and ease the tasks of manufacturers and clients. 

Pharma distributors purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk; this allows manufacturers to focus on their core drug development and manufacturing competencies. They are critical players in the healthcare ecosystem. Ninety-two percent of prescription pharmaceuticals flow through a complex, secure ecosystem composed of patients, providers, pharmacies, distributors, group purchasing organizations (GPOs), manufacturers, pharmacy services administration organizations (PSAOs), pharmacy benefit managers (PBMs).  

Pharmaceutical distributors continue to evolve beyond their flagship offering of core services to enlarge services to ecosystem stakeholders while optimizing costs. In addition to enabling a secure, transparent, and efficient pharmaceutical supply chain that safeguards patient safety, distributors offer value-added services such as independent pharmacy support, generic sourcing programs, hub services, and innovative partnerships. 

Distributors provide services and distribution facilities such as Storage and transporting goods to a required site in the required temperature conditions. 

Ikris Pharma: A pharmaceutical wholesale distributor

Ikris Pharma Network is one of the trusted Pharmaceutical distributors and wholesalers in the Indian market, exporting medical products and medicines globally. 

In the last two years especially during the coronavirus pandemic outbreak, Ikris gave its best shot to supply medicines in Brazil when most of the transportation facilities were at halt.

Ikris is a GDP-certified company having licenses for both wholesale and retail drugs. There are temperature-sensitive drugs that require appropriate storage and transportation under the required temperature, and we are best at catering cold-chain supplies of medicines. 

We have professionals, sophisticated processes, and impeccable reliability. Our aspiration and liability are to keep up to ensure our clients’ supply chains and businesses both succeed and keep flourishing. We believe in completing the assigned task before or on time. That’s why we are emerging as a top pharmaceutical distributor in India and at the global level. 

Fact about Indian Pharmaceutical Manufacturer and distributor

Based on the Annual Report by the Ministry of Chemicals & Fertilizers Department of Pharmaceuticals, Government of India. The Indian Pharma Industry is the world’s 3rd largest by volume and 14th largest in terms of value. The total Annual Turnover of Pharmaceuticals was Rs. 2,89,998 crore for the year 2019-2020. Total pharmaceutical exports and imports were to the tune of Rs. 1,46,260 crore and Rs. 42,943 crore respectively in the year 2019-20.

Major Segments of the Pharmaceutical Industry are Generic drugs, OTC Medicines, API/Bulk Drugs, Vaccines, Contract Research & Manufacturing, Biosimilars & Biologics.

India is 3rd most prominent market for APIs globally, 8% share in the Global API Industry, 500+ different APIs are manufactured in India, and it contributes 57% of APIs to the WHO prequalified list.


Team Ikris